Veeva Vision - s2.q4cdn.com › 456805372 › files › doc_presentations › 2019 › … ·...

24
Veeva Vision Matt Wallach, Co-founder & President January 10, 2019

Transcript of Veeva Vision - s2.q4cdn.com › 456805372 › files › doc_presentations › 2019 › … ·...

Page 1: Veeva Vision - s2.q4cdn.com › 456805372 › files › doc_presentations › 2019 › … · events may cause these expectations to change, and Veeva disclaims any obligation to

Veeva VisionMatt Wallach, Co-founder & President

January 10, 2019

Page 2: Veeva Vision - s2.q4cdn.com › 456805372 › files › doc_presentations › 2019 › … · events may cause these expectations to change, and Veeva disclaims any obligation to

2Copyright © Veeva Systems 2019

Safe HarborForward-looking Statements

This presentation contains forward-looking statements, including statements regarding Veeva's future financial outlook and financial performance, market growth, the

release dates for and benefits from the use of Veeva's solutions, our partnership plans, our strategies, and general business conditions. Any forward-looking statements

contained in this presentation are based upon Veeva's historical performance and its current plans, estimates and expectations and are not a representation that such

plans, estimates, or expectations will be achieved. These forward-looking statements represent Veeva's expectations as of the date of this presentation. Subsequent

events may cause these expectations to change, and Veeva disclaims any obligation to update the forward-looking statements in the future. These forward-looking

statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially, including (i) breaches in our security measures or

unauthorized access to our customers’ data; (ii) our expectation that the future growth rate of our revenues will decline; (iii) fluctuation of our results, which may make

period-to-period comparisons less meaningful; (iv) competitive factors, including but not limited to pricing pressures, consolidation among our competitors, entry of new

competitors, the launch of new products and marketing initiatives by our existing competitors, and difficulty securing rights to access, host or integrate with

complementary third party products or data used by our customers; (v) the rate of adoption of our newer solutions and the results of our efforts to sustain or expand the

use and adoption of our more established applications, like Veeva CRM; (vi) loss of one or more customers, particularly any of our large customers; (vii) system

unavailability, system performance problems, or loss of data due to disruptions or other problems with our computing infrastructure; (viii) failure to sustain the level of

profitability we have achieved in the past as our costs increase; (ix) adverse changes in economic, regulatory, or market conditions, particularly in the life sciences

industry, including as a result of customer mergers; (x) our ability to attract and retain highly skilled employees and manage our growth effectively; (xi) a decline in new

subscriptions that may not be immediately reflected in our operating results due to the ratable recognition of our subscription revenue; and (xii) pending, threatened, or

future legal proceedings and related expenses.

Additional risks and uncertainties that could affect Veeva’s financial results are included under the captions, “Risk Factors” and “Management’s Discussion and Analysis of

Financial Condition and Results of Operations” in the company’s filing on Form 10-Q for the period ended October 31, 2018. This is available on the company’s website at

veeva.com under the Investors section and on the SEC’s website at sec.gov. Further information on potential risks that could affect actual results will be included in other

filings Veeva makes with the SEC from time to time.

Page 3: Veeva Vision - s2.q4cdn.com › 456805372 › files › doc_presentations › 2019 › … · events may cause these expectations to change, and Veeva disclaims any obligation to

3Copyright © Veeva Systems 2019

VisionBuilding the Industry Cloud for Life Sciences

ValuesDo the Right ThingCustomer SuccessEmployee SuccessSpeed

Page 4: Veeva Vision - s2.q4cdn.com › 456805372 › files › doc_presentations › 2019 › … · events may cause these expectations to change, and Veeva disclaims any obligation to

4Copyright © Veeva Systems 2019

The Veeva Way

Customer Success

Innovation & Product Excellence

Strong Growth & Profitability

Big Strategic Markets

Copyright © Veeva Systems 2019

Page 5: Veeva Vision - s2.q4cdn.com › 456805372 › files › doc_presentations › 2019 › … · events may cause these expectations to change, and Veeva disclaims any obligation to

5Copyright © Veeva Systems 2019

Strong Growth and Profitability

Fiscal Year Ending January 31¹ Refer to our latest earnings release dated 11/28/2018 for GAAP to non-GAAP reconciliation.² Restated for ASC 6063 Based on our latest guidance issued 11/28/2018

FY’12 FY’13 FY’14

Revenue Non-GAAP Operating Income1

$61M

$130M

$210M

$313M

$409M

$551M

$7M$30M

$47M

$86M$109M

$173M

FY’15 FY’16 FY’17²

$29M$5M

FY’11 FY’18²

$691M

$219M

FY’193

$856-857M

$299-300M

Page 6: Veeva Vision - s2.q4cdn.com › 456805372 › files › doc_presentations › 2019 › … · events may cause these expectations to change, and Veeva disclaims any obligation to

6Copyright © Veeva Systems 2019

Commercial Cloud

Development Cloud

Outside Life Sciences

Major Areas of the Business

Page 7: Veeva Vision - s2.q4cdn.com › 456805372 › files › doc_presentations › 2019 › … · events may cause these expectations to change, and Veeva disclaims any obligation to

7Copyright © Veeva Systems 2019

Veeva’s TAM is Now $9B+

$8B+Vault QualityOne

Commercial Cloud

$3B

Vault

$4B+

$1B+

Vault QualityOne

$9B+

Commercial Cloud

$3B

Vault

$4B

$1B+

$1B+ New Vault Products Data Workbench, Safety,

SiteDocs, Training

Page 8: Veeva Vision - s2.q4cdn.com › 456805372 › files › doc_presentations › 2019 › … · events may cause these expectations to change, and Veeva disclaims any obligation to

8Copyright © Veeva Systems 2019

LIFE SCIENCES

Drug Development Systems

Commercial Systems

Strategic Technology Partner to Life Sciences

Page 9: Veeva Vision - s2.q4cdn.com › 456805372 › files › doc_presentations › 2019 › … · events may cause these expectations to change, and Veeva disclaims any obligation to

9Copyright © Veeva Systems 2019

Top 10 Life Sciences Software Vendors by Spend

Sources: IDC, Vendor Assessment, #HI240273, March 2013, IDC, Market Share, #US43964017, June 2018

Veeva

Medidata

Oracle

SAP

Dassault

SAS

Parexel

IQVIA

Thermo Fisher

Model N

Oracle

SAP

Medidata

SAS

Accelrys

Thermo Fisher

Cegedim

Parexel

Veeva

TIBCO

1

2

3

4

5

6

7

8

9

10

2012 2017

Page 10: Veeva Vision - s2.q4cdn.com › 456805372 › files › doc_presentations › 2019 › … · events may cause these expectations to change, and Veeva disclaims any obligation to

10Copyright © Veeva Systems 2019

Select Veeva Customers

Enterprise Emerging Growth

675+ customers with users in over 130 countries

Page 11: Veeva Vision - s2.q4cdn.com › 456805372 › files › doc_presentations › 2019 › … · events may cause these expectations to change, and Veeva disclaims any obligation to

11Copyright © Veeva Systems 2019

70+ SERVICES PARTNERS

80+ TECH PARTNERS

Strong and Growing Ecosystem

400+ CONTENT PARTNERS

100+ DATA PARTNERS

Page 12: Veeva Vision - s2.q4cdn.com › 456805372 › files › doc_presentations › 2019 › … · events may cause these expectations to change, and Veeva disclaims any obligation to

Veeva Commercial Cloud

Page 13: Veeva Vision - s2.q4cdn.com › 456805372 › files › doc_presentations › 2019 › … · events may cause these expectations to change, and Veeva disclaims any obligation to

13Copyright © Veeva Systems 2019

CRM Suite Commercial Content

S

Page 14: Veeva Vision - s2.q4cdn.com › 456805372 › files › doc_presentations › 2019 › … · events may cause these expectations to change, and Veeva disclaims any obligation to

14Copyright © Veeva Systems 2019

Expanding Leadership in Commercial

NitroEngage

Approved Email

MedComms

PromoMats

CRM

INNOVATORS EARLY ADOPTERS EARLY MAJORITY MIDDLE MAJORITY LATER ADOPTERS

CLM

Align

OpenData

Events

Network

Market Share

Andi

Page 15: Veeva Vision - s2.q4cdn.com › 456805372 › files › doc_presentations › 2019 › … · events may cause these expectations to change, and Veeva disclaims any obligation to

15Copyright © Veeva Systems 2019

FY14 FY15 FY16 2Q18FY17FY14 FY15 FY16 2Q19FY17 FY18

1.90

2.22

2.47

3.042.84 2.91

147CUSTOMERS

190 212 308CUSTOMERS CUSTOMERS CUSTOMERS

259CUSTOMERS

294CUSTOMERS

Customers Adopting More Commercial Cloud Average Commercial Cloud Products per Customer

Page 16: Veeva Vision - s2.q4cdn.com › 456805372 › files › doc_presentations › 2019 › … · events may cause these expectations to change, and Veeva disclaims any obligation to

16Copyright © Veeva Systems 2019

AI and Cloud Data Warehousing

Intelligent Engagement

CRM Suite Commercial ContentNitro

AndiS

Page 17: Veeva Vision - s2.q4cdn.com › 456805372 › files › doc_presentations › 2019 › … · events may cause these expectations to change, and Veeva disclaims any obligation to

Veeva Development Cloud

Page 18: Veeva Vision - s2.q4cdn.com › 456805372 › files › doc_presentations › 2019 › … · events may cause these expectations to change, and Veeva disclaims any obligation to

18Copyright © Veeva Systems 2019

future

Page 19: Veeva Vision - s2.q4cdn.com › 456805372 › files › doc_presentations › 2019 › … · events may cause these expectations to change, and Veeva disclaims any obligation to

19Copyright © Veeva Systems 2019

CoderClinical Coding

EDCData Capture & Monitoring

Data WorkbenchCleaning, Reporting, Export

Reinventing Clinical Data ManagementOne product for coding, EDC, data cleaning, and data management

Page 20: Veeva Vision - s2.q4cdn.com › 456805372 › files › doc_presentations › 2019 › … · events may cause these expectations to change, and Veeva disclaims any obligation to

20Copyright © Veeva Systems 2019

INNOVATORS EARLY ADOPTERS EARLY MAJORITY MIDDLE MAJORITY LATER ADOPTERS

Training

CDMS

CTMS

Submissions

QualityDocs eTMF

QMSStudy Startup

Subs Archive

Publishing

Registrations

SiteDocsMarket Share

Building Product Leadership in Development Cloud

Safety

Page 21: Veeva Vision - s2.q4cdn.com › 456805372 › files › doc_presentations › 2019 › … · events may cause these expectations to change, and Veeva disclaims any obligation to

21Copyright © Veeva Systems 2019

Vault Adoption AcceleratingAverage Vault products per Vault customer

FY14 FY15 FY16 2Q18FY17FY14 FY15 FY16 2Q19FY17 FY18

1.48 1.52 1.53

2.20

1.82

2.10

69CUSTOMERS

135 219 504CUSTOMERS CUSTOMERS CUSTOMERS

334CUSTOMERS

449CUSTOMERS

Page 22: Veeva Vision - s2.q4cdn.com › 456805372 › files › doc_presentations › 2019 › … · events may cause these expectations to change, and Veeva disclaims any obligation to

22Copyright © Veeva Systems 2019

RegulatoryClinical

Operations Medical CommercialQuality SafetyClinical Data Management

Coding

EDC

Workbench

eTMF

CTMS

Study Startup

QMS

QualityDocs

Training

Submissions

Subs Archive

Registrations

Publishing

SafetyManagement

Medical CRM

MedComms

Oncology Link

OpenData

Multichannel CRM

PromoMats

Nitro

Andi

Veeva Industry Cloud

Page 23: Veeva Vision - s2.q4cdn.com › 456805372 › files › doc_presentations › 2019 › … · events may cause these expectations to change, and Veeva disclaims any obligation to

23Copyright © Veeva Systems 2019

On a Path to Multi-Billion Dollar Cloud Leader

• Continued Innovation and Market Expansion

• Building Long-term Leadership in Strategic Markets

• Powerful and Unique Cloud Platform

• Business Model Advantage – The Veeva Way

Page 24: Veeva Vision - s2.q4cdn.com › 456805372 › files › doc_presentations › 2019 › … · events may cause these expectations to change, and Veeva disclaims any obligation to

Thank you

Thank You